The global C-reactive protein (CRP) testing market is valued at USD 5.58 billion in 2024, expected to reach USD 5.75 billion by 2034, growing at a CAGR of 0.3%. Key drivers include rising inflammation cases, technological advancements, and the demand for point-of-care diagnostics.
Azenta Life Sciences and Frenova, a division of Fresenius Medical Care and a leader in renal precision medicine, have announced… Read More
Zenara Pharma Private Limited, a leading Biophore company, has received final approval from the U.S. Food and Drug Administration (FDA)… Read More
Silexion Therapeutics Corp., a global clinical-stage biotech company specializing in RNA interference (RNAi) therapies, has announced outstanding new preclinical data… Read More
Canada and the UK have joined forces in a groundbreaking project aimed at developing next-generation immunotherapies for malignant melanoma, a… Read More
The liquid filtration for pharmaceutical market is rapidly evolving and is poised to generate hundreds of millions in revenue between… Read More
The global ophthalmology devices market is valued at USD 7.51 billion in 2024 and is projected to grow to USD… Read More